Cite
MLA Citation
G. Lenz et al.. “CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.” Hematological oncology, vol. 35, n.d., pp. 68–69. http://access.bl.uk/ark:/81055/vdc_100047526045.0x00002e